Alpha 2.0
Login Register
» Authors » M Arenbergerova

M Arenbergerova

Explore the profile of M Arenbergerova including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 32
Citations 139
Followers 0
Related Specialties
Infectious Diseases
Dermatology
General Medicine
Top 10 Co-Authors
P Arenberger
S Gkalpakiotis
A Fialova
E Sticova
A M Forsea
A Lallas
J Hugo
I Puzanov
A Srp
T Vedral
Published In
J Eur Acad Dermatol Venereol
Br J Dermatol
Hautarzt
Acta Univ Carol Med (Praha)
Cas Lek Cesk
Affiliations
Soon will be listed here.
Recent Articles
1.
European expert consensus statement on the systemic treatment of alopecia areata
Rudnicka L, Arenbergerova M, Grimalt R, Ioannides D, Katoulis A, Lazaridou E, et al.
J Eur Acad Dermatol Venereol . 2024 Jan; 38(4):687-694. PMID: 38169088
Alopecia areata is an autoimmune form of non-scarring hair loss. It is usually characterized by limited areas of hair loss. However, the disease may progress to complete scalp and body...
2.
Alopecia barbae severity score: a novel scoring system to estimate the extent of beard loss and success of treatment
Stefanis A, Arenberger P, Arenbergerova M, Gkalpakiotis S
Br J Dermatol . 2021 May; 185(4):847-849. PMID: 33997953
No abstract available.
3.
Position statement of the EADV Melanoma Task Force on recommendations for the management of cutaneous melanoma patients during COVID-19
Arenbergerova M, Lallas A, Nagore E, Rudnicka L, Forsea A, Pasek M, et al.
J Eur Acad Dermatol Venereol . 2021 Mar; 35(7):e427-e428. PMID: 33780557
No abstract available.
4.
Coexistence of palmoplantar pustulosis and ichthyosis vulgaris treated by risankizumab
Hugo J, Arenbergerova M, Arenberger P, Gkalpakiotis S
Br J Dermatol . 2021 Mar; 184(6):e195. PMID: 33646608
No abstract available.
5.
Corticosteroid rescue therapy in relapsing hidradenitis suppurativa treated with adalimumab
Arenbergerova M, Gkalpakiotis S, Marques E, Arenberger P, Dahmen R, Smetanova A
J Eur Acad Dermatol Venereol . 2021 Feb; 35(6):e381-e383. PMID: 33539633
No abstract available.
6.
Successful treatment of recalcitrant hidradenitis suppurativa with risankizumab after failure of anti-tumour necrosis factor alpha
Marques E, Arenberger P, Smetanova A, Gkalpakiotis S, Zimova D, Arenbergerova M
Br J Dermatol . 2020 Dec; 184(5):966-967. PMID: 33301601
No abstract available.
7.
COVID-19 in 3 patients treated with immune checkpoint inhibitors for advanced melanoma
Arenbergerova M, Gkalpakiotis S, Arenberger P, Fialova A, Pasek M
J Dermatolog Treat . 2020 Oct; 33(3):1782-1783. PMID: 33092421
No abstract available.
8.
The evolving field of Dermato-oncology and the role of dermatologists: Position Paper of the EADO, EADV and Task Forces, EDF, IDS, EBDV-UEMS and EORTC Cutaneous Lymphoma Task Force
Garbe C, Peris K, Soura E, Forsea A, Hauschild A, Arenbergerova M, et al.
J Eur Acad Dermatol Venereol . 2020 Aug; 34(10):2183-2197. PMID: 32840022
Background: The incidence of skin cancers has been increasing steadily over the last decades. Although there have been significant breakthroughs in the management of skin cancers with the introduction of...
9.
Compliance, safety concerns and anxiety in patients treated with biologics for psoriasis during the COVID-19 pandemic national lockdown: a multicenter study in the Czech Republic
Rob F, Hugo J, Tivadar S, Bohac P, Gkalpakiotis S, Vargova N, et al.
J Eur Acad Dermatol Venereol . 2020 Jun; 34(11):e682-e684. PMID: 32594549
No abstract available.
10.
Dupilumab therapy in a patient with atopic dermatitis and severe atopic keratoconjunctivitis
Gkalpakiotis S, Arenberger P, Skalicka P, Arenbergerova M
J Eur Acad Dermatol Venereol . 2020 Feb; 34(6):e281-e283. PMID: 32031716
No abstract available.